Mark I NAAK
Mark I NAAK, also known as the Mark I Nerve Agent Antidote Kit, is a medical countermeasure used by military and civilian first responders to treat individuals exposed to nerve agents. Nerve agents are a class of phosphorus-containing organic chemicals that disrupt the mechanisms by which nerves transfer messages to organs. Exposure to nerve agents can lead to severe symptoms and even death, making the availability of antidotes like the Mark I NAAK critical in environments where these agents may be present.
Overview[edit]
The Mark I NAAK consists of two auto-injectors containing atropine and pralidoxime chloride (2-PAM chloride), respectively. Atropine works by blocking the action of acetylcholine, a neurotransmitter that can become dangerously overactive following exposure to nerve agents. Pralidoxime chloride acts by reactivating acetylcholinesterase, an enzyme inhibited by nerve agents, thereby allowing it to resume its normal function of breaking down acetylcholine.
Usage[edit]
The kit is designed for self-administration or administration by a buddy in a field setting, providing immediate first aid until professional medical treatment can be obtained. The recommended use involves first administering the atropine injection to alleviate the symptoms caused by excessive acetylcholine. This is followed by the administration of pralidoxime chloride to target the underlying cause of the symptoms by reactivating acetylcholinesterase.
History[edit]
The development of the Mark I NAAK was driven by the need for effective countermeasures against nerve agent exposure during the Cold War. Its design allows for rapid administration of antidotes, a critical factor in improving survival rates following exposure.
Current Status[edit]
Over the years, the Mark I NAAK has been supplemented and partially replaced by newer antidote kits, such as the Antidote Treatment Nerve Agent Auto-Injector (ATNAA) and the Convulsant Antidote for Nerve Agent (CANA) which offer improved efficacy and ease of use. However, the Mark I NAAK remains a significant development in the field of chemical defense and continues to be studied for its historical importance and potential applications in future countermeasure strategies.
See Also[edit]
Mark I NAAK[edit]
-
Mark I NAAK
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
